Abstract

To improve the tumor-targeting efficacy of photodynamic therapy, biotin was conjugated with chlorin e6 to develop a new tumor-targeting photosensitizer, Ce6-biotin. The Ce6-biotin had good water solubility and low aggregation. The singlet-oxygen generation rate of Ce6-biotin was slightly increased compared to Ce6. Flow cytometry and confocal laser scanning microscopy results confirmed Ce6-biotin had higher binding affinity toward biotin-receptor-positive HeLa human cervical carcinoma cells than its precursor, Ce6. Due to the BR-targeting ability of Ce6-biotin, it exhibited stronger cytotoxicity to HeLa cells upon laser irradiation. The IC50 against HeLa cells of Ce6-biotin and Ce6 were 1.28 µM and 2.31 µM, respectively. Furthermore, both Ce6-biotin and Ce6 showed minimal dark toxicity. The selectively enhanced therapeutic efficacy and low dark toxicity suggest that Ce6-biotin is a promising PS for BR-positive-tumor-targeting photodynamic therapy.

Highlights

  • Photodynamic therapy (PDT) is based on the local activation of photosensitizers (PSs) in tumors to induce chemical damage, leading to tumor cell death [1,2]

  • Scheme 1 shows the synthetic route of Chlorin e6 (Ce6)-biotin

  • A Boc-protected amino group was linked to the biotin molecule to obtain compound 2 through Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDCI) reaction

Read more

Summary

Introduction

Photodynamic therapy (PDT) is based on the local activation of photosensitizers (PSs) in tumors to induce chemical damage, leading to tumor cell death [1,2]. This method has become a clinically promising approach for treatment of cancers and a wide range of other diseases. The PSs activate oxygen to the singlet state and damage the nearby cells [3,4,5]. The poor selectivity of PSs to tumors is still an obstacle that severely limits their clinical application in PDT [8,9]. Much research has been devoted to improving the targeting ability of PSs

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call